Pratia Invests in Bulgarian Clinical Research Union
Pratia Inc’s recent investment in the Bulgarian Clinical Research Union covers 18 research sites, of which 13 are embedded hospital research units. Pratia's offering now combines over 90 dedicated and embedded Research Sites across six countries. The network provides research in a wide range of therapeutic areas, including oncology, hemato- oncology, vaccines, infectious and autoimmune diseases.
The core element of the Research Network processes integration at Pratia remains the digital platform for managing and conducting clinical trials—the hyggio system.
For more information, click here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Expands Farapulse PFA Approval to Persistent AF After Strong ADVANTAGE AF Trial Results
July 7th 2025Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, following 12-month data from the ADVANTAGE AF trial showing strong safety, high freedom from AF, and no major complications.
